{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:17:46Z","timestamp":1775715466436,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.diabres.2023.110735","type":"journal-article","created":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T01:56:53Z","timestamp":1685757413000},"page":"110735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Real-life 24-week changes in glycemic parameters among European users of flash glucose monitoring with type 1 and 2 diabetes and different levels of glycemic control"],"prefix":"10.1016","volume":"201","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2407-3370","authenticated-orcid":false,"given":"Annel","family":"Lameijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia J.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalvin","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5481-2387","authenticated-orcid":false,"given":"Rijk O.B.","family":"Gans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-346X","authenticated-orcid":false,"given":"Henk J.G.","family":"Bilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-2504","authenticated-orcid":false,"given":"Timothy C.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110735_b0005","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4093\/dmj.2019.0121","article-title":"Continuous glucose monitoring sensors for diabetes management: A review of technologies and applications","volume":"43","author":"Cappon","year":"2019","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.diabres.2023.110735_b0010","doi-asserted-by":"crossref","first-page":"107559","DOI":"10.1016\/j.jdiacomp.2020.107559","article-title":"Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life","volume":"34","author":"Ang","year":"2020","journal-title":"J Diabetes Complications"},{"issue":"9","key":"10.1016\/j.diabres.2023.110735_b0015","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.2337\/dc20-0738","article-title":"Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit","volume":"43","author":"Deshmukh","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13300-019-00720-0","article-title":"The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: A meta-analysis of clinical trials and real-world observational studies","volume":"11","author":"Evans","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2023.110735_b0025","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa2205650","article-title":"Intermittently scanned continuous glucose monitoring for type 1 diabetes","volume":"387","author":"Leelarathna","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2023.110735_b0030","first-page":"100237","article-title":"Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5)","volume":"22","author":"Lameijer","year":"2020","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.diabres.2023.110735_b0035","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/dci17-0041","article-title":"The use of language in diabetes care and education","volume":"40","author":"Dickinson","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0040","doi-asserted-by":"crossref","first-page":"e002124","DOI":"10.1136\/bmjdrc-2021-002124","article-title":"Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6)","volume":"9","author":"Lameijer","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2023.110735_b0045","first-page":"7","article-title":"Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4)","author":"Fokkert","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2023.110735_b0050","first-page":"927","article-title":"Effectiveness of the freestyle libre flash glucose monitoring system on diabetes distress among individuals with type 1 diabetes: A prospective study","volume":"11","author":"Al Hayek","year":"2020","journal-title":"Diabetes Ther Res Treat Educ Diabetes Relat Disord"},{"key":"10.1016\/j.diabres.2023.110735_b0055","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in france: The RELIEF study","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0060","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/dia.2022.0085","article-title":"Reduced rate of acute diabetes events with flash glucose monitoring is sustained for 2 years after initiation: Extended outcomes from the RELIEF study","volume":"24","author":"Riveline","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2023.110735_b0065","doi-asserted-by":"crossref","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: Recommendations from the international consensus on time in range","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0070","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00125-019-05027-0","article-title":"Positioning time in range in diabetes management","volume":"63","author":"Advani","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.110735_b0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: A prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0080","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0085","doi-asserted-by":"crossref","first-page":"e002573","DOI":"10.1136\/bmjdrc-2021-002573","article-title":"Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: A systematic review","volume":"10","author":"Raj","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2023.110735_b0090","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1210\/clinem\/dgab688","article-title":"Relationship between time in range, glycemic variability, HbA1c, and complications in adults with type 1 diabetes mellitus","volume":"107","author":"El Malahi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.110735_b0095","doi-asserted-by":"crossref","first-page":"e14854","DOI":"10.1111\/dme.14854","article-title":"Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: A systematic review and meta-analysis of randomised controlled trials","volume":"39","author":"Elbalshy","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2023.110735_b0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-8587(22)00352-7","article-title":"Effect of switching from intermittently scanned to real-time continuous glucose monitoring in adults with type 1 diabetes: 24-month results from the randomised ALERTT1 trial","volume":"11","author":"Visser","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2023.110735_b0105","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13098-021-00654-3","article-title":"A review of flash glucose monitoring in type 2 diabetes","volume":"13","author":"Krakauer","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.diabres.2023.110735_b0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1932296820958754","article-title":"Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes","volume":"16","author":"Alva","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabres.2023.110735_b0115","unstructured":"Freestyle Libre | Software Disclaimer | Abbott n.d. https:\/\/www.freestyle.abbott\/ca\/en\/products\/libre\/software\/disclaimer.html (accessed December 31, 2020)."},{"key":"10.1016\/j.diabres.2023.110735_b0120","doi-asserted-by":"crossref","first-page":"e000611","DOI":"10.1136\/bmjdrc-2018-000611","article-title":"Flash glucose monitoring improves glycemia in higher risk patients: A longitudinal, observational study under real-life settings","volume":"7","author":"Jangam","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2023.110735_b0125","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: A multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2023.110735_b0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc19-1610","article-title":"Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): A prospective observational real-world cohort study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0135","doi-asserted-by":"crossref","first-page":"819","DOI":"10.4103\/2230-8210.117219","article-title":"Hypoglycemia: The neglected complication","volume":"17","author":"Kalra","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.110735_b0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12933-020-01085-6","article-title":"Glycemic variability: Adverse clinical outcomes and how to improve it?","volume":"19","author":"Zhou","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2023.110735_b0145","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s13300-017-0255-6","article-title":"Use of flash glucose-sensing technology for 12 months as a replacement for blood glucose monitoring in insulin-treated type 2 diabetes","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.diabres.2023.110735_b0150","doi-asserted-by":"crossref","first-page":"e002590","DOI":"10.1136\/bmjdrc-2021-002590","article-title":"Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: A retrospective real-world chart review study and meta-analysis","volume":"10","author":"Carlson","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2023.110735_b0155","doi-asserted-by":"crossref","DOI":"10.1177\/14791641211021374","article-title":"The impact of flash glucose monitoring on glycated hemoglobin in type 2 diabetes managed with basal insulin in Canada: A retrospective real-world chart review study","volume":"18","author":"Elliott","year":"2021","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/j.diabres.2023.110735_b0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1559827619890955","article-title":"Flash glucose monitoring technology impact on diabetes self-care behavior","volume":"14","author":"White","year":"2019","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/j.diabres.2023.110735_b0165","doi-asserted-by":"crossref","first-page":"e001115","DOI":"10.1136\/bmjdrc-2019-001115","article-title":"Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: A randomized controlled trial","volume":"8","author":"Wada","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabres.2023.110735_b0170","doi-asserted-by":"crossref","first-page":"108897","DOI":"10.1016\/j.diabres.2021.108897","article-title":"Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters","author":"Lameijer","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110735_b0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2017.12.015","article-title":"Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: A European analysis of over 60 million glucose tests","volume":"137","author":"Dunn","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110735_b0180","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/dom.14906","article-title":"Continuous glucose monitoring metrics (Mean Glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy","volume":"25","author":"Rodbard","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2023.110735_b0185","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1007\/s00125-011-2313-3","article-title":"Do men develop type 2 diabetes at lower body mass indices than women?","volume":"54","author":"Logue","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.110735_b0190","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1210\/jc.2016-1915","article-title":"Higher prevalence of Type 2 diabetes in men than in women is associated with differences in visceral fat mass","volume":"101","author":"Nordstr\u00f6m","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.110735_b0195","unstructured":"The gender pay gap situation in the EU. Eur Comm - Eur Comm n.d. https:\/\/ec.europa.eu\/info\/policies\/justice-and-fundamental-rights\/gender-equality\/equal-pay\/gender-pay-gap-situation-eu_en (accessed September 11, 2022)."},{"key":"10.1016\/j.diabres.2023.110735_b0200","doi-asserted-by":"crossref","first-page":"101417","DOI":"10.1016\/j.diabet.2022.101417","article-title":"Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs), it\u2019s time to give more credits to patients\u2019 voice in research: The example of assessing hypoglycemia burden","volume":"49","author":"Wu","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2023.110735_b0205","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): A new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110735_b0210","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/dc08-0545","article-title":"Translating the A1C assay into estimated average glucose values","volume":"31","author":"Nathan","year":"2008","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:26:33Z","timestamp":1759173993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723004989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":42,"alternative-id":["S0168822723004989"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110735","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-life 24-week changes in glycemic parameters among European users of flash glucose monitoring with type 1 and 2 diabetes and different levels of glycemic control","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110735"}}